Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.91% | 75.24 | 1.0% | $2009.70m | |
| AMGN | Amgen, Inc. | -1.94% | 204.45 | 1.3% | $926.20m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.21% | 472.01 | 2.6% | $800.61m | |
| BIIB | Biogen, Inc. | -0.25% | 315.34 | 1.5% | $749.71m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.85% | 236.22 | 1.9% | $574.76m | |
| MRNA | Moderna, Inc. | -1.63% | 29.98 | 0.0% | $553.41m | |
| ILMN | Illumina, Inc. | -1.22% | 272.88 | 3.5% | $472.48m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.17% | 89.15 | 2.0% | $284.67m | |
| A | Agilent Technologies, Inc. | -1.07% | 71.89 | 1.6% | $234.15m | |
| EXAS | EXACT Sciences Corp. | -0.34% | 58.23 | 21.0% | $199.97m | |
| INCY | Incyte Corp. | 1.57% | 73.30 | 2.5% | $179.50m | |
| SGEN | Seattle Genetics, Inc. | 1.37% | 116.87 | 6.1% | $172.04m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 3.09% | 85.04 | 4.3% | $165.84m | |
| NVAX | Novavax, Inc. | -2.66% | 13.92 | 114.7% | $129.97m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 1.72% | 110.70 | 8.7% | $103.08m |
Company Profile
Actinium Pharmaceuticals, Inc. is a clinical-stage, Biopharmaceutical Company focused on developing and potentially commercializing therapies to cell therapies. The firm's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.